Literature DB >> 2173799

The clinical features and prognosis of hepatoblastoma: follow-up studies done on pediatric tumors enrolled in the Japanese Pediatric Tumor Registry between 1971 and 1980. Part I. Committee of Malignant Tumors, Japanese Society of Pediatric Surgeons.

Y Hata1.   

Abstract

Retrospective follow-up studies were conducted on 101 cases of hepatoblastoma enrolled in the registry established by the Committee of Malignant Tumors of the Japanese Society of Pediatric Surgeons between 1971 and 1980. The disease was classified into the following 5 categories; namely, stages I, II, IIIA, IIIB and IV according to local involvement (factor C), vascular invasion (factor V), lymph node involvement (factor N), and distant metastasis (factor M). The results were analysed as the relation between two-year tumor-free survival rate (2YTFSR) and various factors. The overall 2YTFSR of 42 per cent was found to be related to the staging system, age and quality of resection, and our results indicated that cure could be achieved by complete resection of the tumor.

Entities:  

Mesh:

Year:  1990        PMID: 2173799     DOI: 10.1007/BF02471004

Source DB:  PubMed          Journal:  Jpn J Surg        ISSN: 0047-1909


  5 in total

1.  Hepatoblastoma and hepatocarcinoma in children: analysis of a series of 29 cases.

Authors:  F Gauthier; J Valayer; B L Thai; M Sinico; C Kalifa
Journal:  J Pediatr Surg       Date:  1986-05       Impact factor: 2.545

2.  Histologic classification of liver-cell carcinoma in infancy and childhood and its clinical evaluation. A study of 70 cases collected in Japan.

Authors:  M Kasai; I Watanabe
Journal:  Cancer       Date:  1970-03       Impact factor: 6.860

3.  Histopathology and prognosis in childhood hepatoblastoma and hepatocarcinoma.

Authors:  J E Haas; K A Muczynski; M Krailo; A Ablin; V Land; T J Vietti; G D Hammond
Journal:  Cancer       Date:  1989-09-01       Impact factor: 6.860

4.  The proposed Japanese TNM classification of primary liver carcinoma in infants and children.

Authors:  K Morita; I Okabe; J Uchino; I Watanabe; M Iwabuchi; S Matsuyama; H Takahashi; T Nakajo; Y Hirai; Y Tsuchida; K Katsumata; H Hasegawa; T Nishi; E Okamoto; K Ikeda
Journal:  Jpn J Clin Oncol       Date:  1983-06       Impact factor: 3.019

5.  Liver tumors in children in the particular reference to hepatoblastoma and hepatocellular carcinoma: American Academy of Pediatrics Surgical Section Survey--1974.

Authors:  P R Exelby; R M Filler; J L Grosfeld
Journal:  J Pediatr Surg       Date:  1975-06       Impact factor: 2.545

  5 in total
  3 in total

1.  Efficacy of preoperative transcatheter arterial chemoembolization combined with systemic chemotherapy for treatment of unresectable hepatoblastoma in children.

Authors:  Masakazu Hirakawa; Akihiro Nishie; Yoshiki Asayama; Nobuhiro Fujita; Kousei Ishigami; Tatsurou Tajiri; Tomoaki Taguchi; Hiroshi Honda
Journal:  Jpn J Radiol       Date:  2014-06-13       Impact factor: 2.374

2.  High expression of telomerase is an independent prognostic indicator of poor outcome in hepatoblastoma.

Authors:  E Hiyama; H Yamaoka; T Matsunaga; Y Hayashi; H Ando; S Suita; H Horie; M Kaneko; F Sasaki; K Hashizume; A Nakagawara; N Ohnuma; T Yokoyama
Journal:  Br J Cancer       Date:  2004-08-31       Impact factor: 7.640

3.  Prognostic Factors for Event-Free Survival in Pediatric Patients with Hepatoblastoma Based on the 2017 PRETEXT and CHIC-HS Systems.

Authors:  Hee Mang Yoon; Jisun Hwang; Kyung Won Kim; Jung-Man Namgoong; Dae Yeon Kim; Kyung-Nam Koh; Hyery Kim; Young Ah Cho
Journal:  Cancers (Basel)       Date:  2019-09-18       Impact factor: 6.639

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.